EBS - Emergent BioSolutions extends shelf life of Narcan to 4 years
2024-01-17 14:46:11 ET
More on Emergent BioSolutions
- Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
- Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
- Emergent BioSolutions Inc. 2023 Q3 - Results - Earnings Call Presentation
- Emergent BioSolutions wins $235.8M DoD contract
- Emergent Biosolutions receives NYSE notice regarding delayed form 10-Q filing
For further details see:
Emergent BioSolutions extends shelf life of Narcan to 4 years